185 related articles for article (PubMed ID: 32403097)
1. Nano magnetic liposomes-encapsulated parthenolide and glucose oxidase for ultra-efficient synergistic antitumor therapy.
Gao W; Wei S; Li Z; Li L; Zhang X; Li C; Gao D
Nanotechnology; 2020 Aug; 31(35):355104. PubMed ID: 32403097
[TBL] [Abstract][Full Text] [Related]
2. Nanomagnetic liposome-encapsulated parthenolide and indocyanine green for targeting and chemo-photothermal antitumor therapy.
Gao W; Li L; Zhang X; Luo L; He Y; Cong C; Gao D
Nanomedicine (Lond); 2020 Apr; 15(9):871-890. PubMed ID: 32223505
[No Abstract] [Full Text] [Related]
3. Magnetic Targeting, Tumor Microenvironment-Responsive Intelligent Nanocatalysts for Enhanced Tumor Ablation.
Feng L; Xie R; Wang C; Gai S; He F; Yang D; Yang P; Lin J
ACS Nano; 2018 Nov; 12(11):11000-11012. PubMed ID: 30339353
[TBL] [Abstract][Full Text] [Related]
4. Fusiform-Like Copper(II)-Based Metal-Organic Framework through Relief Hypoxia and GSH-Depletion Co-Enhanced Starvation and Chemodynamic Synergetic Cancer Therapy.
Wang Z; Liu B; Sun Q; Dong S; Kuang Y; Dong Y; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17254-17267. PubMed ID: 32227859
[TBL] [Abstract][Full Text] [Related]
5. Preparation and characterization of parthenolide nanocrystals for enhancing therapeutic effects of sorafenib against advanced hepatocellular carcinoma.
Liang P; Wu H; Zhang Z; Jiang S; Lv H
Int J Pharm; 2020 Jun; 583():119375. PubMed ID: 32344021
[TBL] [Abstract][Full Text] [Related]
6. Hierarchically decorated magnetic nanoparticles amplify the oxidative stress and promote the chemodynamic/magnetic hyperthermia/immune therapy.
Hu A; Pu Y; Xu N; Yang H; Hu X; Sun R; Jin R; Nie Y
Acta Biomater; 2024 Jan; 173():457-469. PubMed ID: 37984631
[TBL] [Abstract][Full Text] [Related]
7. GSH-Responsive Organosilica Hybrid Nanosystem as a Cascade Promoter for Enhanced Starvation and Chemodynamic Therapy.
Wu H; Li X; Liu S; Wang Q; Cao Y; Hao JN; Li Y
Adv Healthc Mater; 2023 Jan; 12(2):e2201262. PubMed ID: 36213949
[TBL] [Abstract][Full Text] [Related]
8. MOF-derived cobalt-iron containing nanocomposite with cascade-catalytic activities for multimodal synergistic tumor therapy.
Jiang Y; Lu H; Lei L; Yuan X; Scherman D; Liu Y
Colloids Surf B Biointerfaces; 2024 Aug; 240():113981. PubMed ID: 38815310
[TBL] [Abstract][Full Text] [Related]
9. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
Wang W; Adachi M; Zhang R; Zhou J; Zhu D
Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982
[TBL] [Abstract][Full Text] [Related]
10. Engineering tumor-specific catalytic nanosystem for NIR-II photothermal-augmented and synergistic starvation/chemodynamic nanotherapy.
Zhou S; Xu J; Dai Y; Wei Y; Chen L; Feng W; Chen Y; Ni X
Biomater Res; 2022 Nov; 26(1):66. PubMed ID: 36435848
[TBL] [Abstract][Full Text] [Related]
11. Novel Tumor-Microenvironment-Based Sequential Catalytic Therapy by Fe(II)-Engineered Polydopamine Nanoparticles.
Zhu Y; Xin N; Qiao Z; Chen S; Zeng L; Zhang Y; Wei D; Sun J; Fan H
ACS Appl Mater Interfaces; 2019 Nov; 11(46):43018-43030. PubMed ID: 31660723
[TBL] [Abstract][Full Text] [Related]
12. Copper peroxide coated upconversion nanoparticle modified with glucose oxidase for H
Hong Y; Tao Q; Liu YY; Wang Z; Wang H; Sun L
Dalton Trans; 2022 Aug; 51(30):11325-11334. PubMed ID: 35838196
[TBL] [Abstract][Full Text] [Related]
13. Rapid Decomposition and Catalytic Cascade Nanoplatforms Based on Enzymes and Mn-Etched Dendritic Mesoporous Silicon for MRI-Guided Synergistic Therapy.
Liu B; Wang Z; Li T; Sun Q; Dong S; Zhong C; Yang D; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45772-45788. PubMed ID: 32969221
[TBL] [Abstract][Full Text] [Related]
14. Biodegradable Nanocatalyst with Self-Supplying Fenton-like Ions and H
Li W; Zhou X; Liu S; Zhou J; Ding H; Gai S; Li R; Zhong L; Jiang H; Yang P
ACS Appl Mater Interfaces; 2021 Nov; 13(43):50760-50773. PubMed ID: 34672620
[TBL] [Abstract][Full Text] [Related]
15. One-Pot Rapid Synthesis of Cu
Li Q; Yu J; Lin L; Zhu Y; Wei Z; Wan F; Zhang X; He F; Tian L
ACS Appl Mater Interfaces; 2023 Apr; 15(13):16482-16491. PubMed ID: 36972557
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Specific Expansion of Oxidative Stress by Glutathione Depletion and Use of a Fenton Nanoagent for Enhanced Chemodynamic Therapy.
Chen Q; Zhou J; Chen Z; Luo Q; Xu J; Song G
ACS Appl Mater Interfaces; 2019 Aug; 11(34):30551-30565. PubMed ID: 31397998
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Specific Endogenous Fe
Fan Z; Jiang B; Zhu Q; Xiang S; Tu L; Yang Y; Zhao Q; Huang D; Han J; Su G; Ge D; Hou Z
ACS Appl Mater Interfaces; 2020 Apr; 12(13):14884-14904. PubMed ID: 32167740
[TBL] [Abstract][Full Text] [Related]
18. Triggering Sequential Catalytic Fenton Reaction on 2D MXenes for Hyperthermia-Augmented Synergistic Nanocatalytic Cancer Therapy.
Liang R; Li Y; Huo M; Lin H; Chen Y
ACS Appl Mater Interfaces; 2019 Nov; 11(46):42917-42931. PubMed ID: 31635454
[TBL] [Abstract][Full Text] [Related]
19. Synergistically enhanced multienzyme catalytic nanoconjugates for efficient cancer therapy.
Yin SY; Liu W; Yang J; Li J
J Mater Chem B; 2021 Jul; 9(29):5877-5886. PubMed ID: 34259273
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment responsive self-cascade catalysis for synergistic chemo/chemodynamic therapy by multifunctional biomimetic nanozymes.
Zheng N; Fu Y; Liu X; Zhang Z; Wang J; Mei Q; Wang X; Deng G; Lu J; Hu J
J Mater Chem B; 2022 Jan; 10(4):637-645. PubMed ID: 34991154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
